Sun Pharmaceuticals Industries Ltd logo

SUNPHARMA

Sun Pharmaceuticals Industries Ltd

₹1,191.35

Sun Pharmaceuticals Industries Ltd Q2 FY2023-2024 Results: Summary

Revenue
₹12,486.02Cr
Net Profits
₹2,375.51Cr
Net Profit Margins
19.03%

Highlights

Revenue:

Sun Pharmaceuticals Industries Ltd’s revenue jumped 13.12% since last year same period to ₹12,486.02Cr in the Q2 2023-2024. On a quarterly growth basis, Sun Pharmaceuticals Industries Ltd has generated 2.81% jump in its revenue since last 3-months.

Net Profits:

Sun Pharmaceuticals Industries Ltd’s net profit jumped 5.01% since last year same period to ₹2,375.51Cr in the Q2 2023-2024. On a quarterly growth basis, Sun Pharmaceuticals Industries Ltd has generated 17.45% jump in its net profits since last 3-months.

Net Profit Margins:

Sun Pharmaceuticals Industries Ltd’s net profit margin fell -7.17% since last year same period to 19.03% in the Q2 2023-2024. On a quarterly growth basis, Sun Pharmaceuticals Industries Ltd has generated 14.25% jump in its net profit margins since last 3-months.

FAQs

The revenue for Sun Pharmaceuticals Industries Ltd in the Q2 results 2023 was ₹12,486.02Cr.

The net profit for Sun Pharmaceuticals Industries Ltd in the Q2 results 2023 was ₹2,375.51Cr.

The net profit margin for Sun Pharmaceuticals Industries Ltd in the Q2 results 2023 was 19.03%.

The revenue for Sun Pharmaceuticals Industries Ltd in the Q2 results 2022 was ₹11,037.50Cr.

The net profit for Sun Pharmaceuticals Industries Ltd in the Q2 results 2022 was ₹2,262.22Cr.

The net profit margin for Sun Pharmaceuticals Industries Ltd in the Q2 results 2022 was 20.50%.